Mullerian inhibiting substance in human testes after birth.

Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes.

Mullerian inhibiting substance binding and uptake.

Serum levels of Mullerian inhibiting substance in boys with cryptorchidism.

Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.

Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.

The preservation of Mullerian inhibiting substance during long-term freezing of testicular fragments.

An update on Mullerian-inhibiting substance: its potential application against ovarian cancer.

Involution of the female Mullerian duct of the fetal rat in the organ-culture assay for the detection of Mullerian Inhibiting Substance.

Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.

Directed expression of an oncogene to Sertoli cells in transgenic mice using mullerian inhibiting substance regulatory sequences.

Prediction of assisted reproductive technique outcome in elevated early follicular phase follicle stimulating hormone with Mullerian inhibiting substance level.

Müllerian inhibiting substance in reproduction and cancer.

Gonadotropin control of müllerian-inhibiting substance.

Identification of müllerian inhibiting substance specific binding in human cell lines.

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.

To what extent does Anti-Mullerian Hormone contribute to a better prediction of live birth after IVF?

E-rosette inhibiting substance in Hodgkin's disease spleen extracts.

Evidence for a foot-inhibiting substance in hydra.

Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects.

Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.

Effect of the cholinesterase inhibiting substance galanthamine on human EEG and visual evoked potentials.

Cellular localization of müllerian inhibiting substance messenger ribonucleic acid during human ovarian follicular development.

Bioassay, purification, cloning, and expression of müllerian inhibiting substance.

Sex-specific fetal lung development and müllerian inhibiting substance.

Suggest Documents

Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes.

Mullerian inhibiting substance binding and uptake.

Serum levels of Mullerian inhibiting substance in boys with cryptorchidism.

Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.

Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.

The preservation of Mullerian inhibiting substance during long-term freezing of testicular fragments.

An update on Mullerian-inhibiting substance: its potential application against ovarian cancer.

Involution of the female Mullerian duct of the fetal rat in the organ-culture assay for the detection of Mullerian Inhibiting Substance.

Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.

Directed expression of an oncogene to Sertoli cells in transgenic mice using mullerian inhibiting substance regulatory sequences.

Prediction of assisted reproductive technique outcome in elevated early follicular phase follicle stimulating hormone with Mullerian inhibiting substance level.

Müllerian inhibiting substance in reproduction and cancer.

Gonadotropin control of müllerian-inhibiting substance.

Identification of müllerian inhibiting substance specific binding in human cell lines.

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.

To what extent does Anti-Mullerian Hormone contribute to a better prediction of live birth after IVF?

E-rosette inhibiting substance in Hodgkin's disease spleen extracts.

Evidence for a foot-inhibiting substance in hydra.

Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects.

Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.

Effect of the cholinesterase inhibiting substance galanthamine on human EEG and visual evoked potentials.

Cellular localization of müllerian inhibiting substance messenger ribonucleic acid during human ovarian follicular development.

Bioassay, purification, cloning, and expression of müllerian inhibiting substance.

Sex-specific fetal lung development and müllerian inhibiting substance.

Mullerian inhibiting substance in human testes after birth.

Recommend Documents

Follow Us